OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
23
Results
Show all
Save search
Copy query
Show results for
Unknown
(23)
Publication Date
Release Date
2025
(6)
2024
(4)
2022
(3)
2021
(3)
2008
(3)
2023
(2)
2015
(1)
2010
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Biomass-derived cellulose nanofibers and iron oxide-based nanohybrids for thermal insulation application.
Not available
S-EPMC9417942
|
biostudies-literature
Cite
International Alliance of Urolithiasis (IAU) consensus on miniaturized percutaneous nephrolithotomy.
Not available
S-EPMC11514913
|
biostudies-literature
Cite
Failure to validate association between 12p13 variants and ischemic stroke.
Not available
S-EPMC2978046
|
biostudies-literature
Cite
Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis.
Not available
S-EPMC9112652
|
biostudies-literature
Cite
The Effect of Incidental Consolidation on Management and Outcomes in COPD Exacerbations: Data from the European COPD Audit.
Not available
S-EPMC4516303
|
biostudies-literature
Cite
Correction : Epidemiology and outcomes of early-onset AKI in COVID-19-related ARDS in comparison with non-COVID-19-related ARDS: insights from two prospective global cohort studies.
Not available
S-EPMC10214330
|
biostudies-literature
Cite
Variability of oxygen requirements in critically ill COVID-19 patients.
Not available
S-EPMC10884784
|
biostudies-literature
Cite
Presentation, care, and outcomes of patients with NSTEMI according to World Bank country income classification: the ACVC-EAPCI EORP NSTEMI Registry of the European Society of Cardiology.
Not available
S-EPMC10495699
|
biostudies-literature
Cite
The global, regional, and national burden of cancer, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023.
Not available
S-EPMC12687902
|
biostudies-literature
Cite
Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study.
Not available
S-EPMC2772657
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets